Objetivo
EBiSC is designed to address the increasing demand by iPSC researchers for quality-controlled, disease-relevant research grade iPSC lines, data and cell services. Its goal is to demonstrate an operational banking and distribution service of iPSC lines after 3 years and to establish subsequently for Europe a centralised, not-for-profit bank providing all qualified users with access to scalable, cost-efficient and customised products. The EBiSC Consortium including EFPIA partners boasts the leadership, scientific expertise, facilities, networks and experience to achieve these goals and, being representative of all stakeholders from tissue donors to clinical and academic iPSC researchers and industrial users, to respond appropriately to advances in science and society. Led by Pfizer Ltd and managed by Roslin Cells, the Consortium comprises 8 active participant iPSC Centres with clinical and patient networks, a global leader in industrial iPSC supply, international experts in iPSC science, biobanking, bioengineering and regenerative medicine, and scholars in law and ethics. The main facility will be at the Babraham Research Campus (Cambridge, UK) and will undertake cell expansion, QC and characterisation. The European Cell Culture Collection (ECACC) of Public Health England (Department of Health, UK) will coordinate cell line distribution. The Fraunhofer IBMT (Saarbrücken, Germany) will provide comprehensive operational back up. EBiSC’s capacity will be 10,000 cell lines; it will eventually process over 1,000 lines in annual sales. In a phased business strategy EBiSC will hot-start distribution of lines contributed by iPSC Centres in 2014, lines collected based on specified user demand, will reach full scale operations in 2016, and with extended funding will become self-sustaining as a not for profit banking operation by 2019. EBiSC will spearhead Europe in the international standardisation of iPSC banking by forging collaborative links with similar endeavours in the USA and Asia. Through market research, stakeholder engagement, incentives and training, EBiSC will promote wider participation and use, maximise the value of the research resource, and secure its longevity. EBiSC will promote iPSC technology and global iPSC banking, strengthen the competitiveness of European R&D, and enhance the health and wealth of nations.
Ámbito científico
Convocatoria de propuestas
IMI-JU-08-2012
Consulte otros proyectos de esta convocatoria
Régimen de financiación
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinador
2340 Beerse
Bélgica
Ver en el mapa
Participantes (28)
EH8 9YL Edinburgh
Ver en el mapa
La participación finalizó
EH25 9PP Roslin, Midlothian
Ver en el mapa
80686 Munchen
Ver en el mapa
CB10 1SA SAFFRON WALDEN
Ver en el mapa
4057 Basel
Ver en el mapa
69117 Heidelberg
Ver en el mapa
10117 Berlin
Ver en el mapa
NE1 7RU Newcastle Upon Tyne
Ver en el mapa
50937 Koeln
Ver en el mapa
30167 Hannover
Ver en el mapa
1011 JV AMSTERDAM
Ver en el mapa
La participación finalizó
22525 Hamburg
Ver en el mapa
WC1E 6BT London
Ver en el mapa
LS2 7UE Leeds
Ver en el mapa
2970 Hoersholm
Ver en el mapa
53127 Bonn
Ver en el mapa
CB2 1PH Cambridge
Ver en el mapa
75008 Paris
Ver en el mapa
28029 Madrid
Ver en el mapa
151 85 Sodertaelje
Ver en el mapa
2500 Valby
Ver en el mapa
2880 Bagsvaerd
Ver en el mapa
La participación finalizó
1070 Bruxelles / Brussel
Ver en el mapa
CT13 9NJ Sandwich
Ver en el mapa
1070 Bruxelles / Brussel
Ver en el mapa
51373 Leverkusen
Ver en el mapa
EH25 9PP Roslin, Midlothian
Ver en el mapa
RG21 4FA Basingstoke
Ver en el mapa